reast cancer is one of the most common cancers in women, with an estimated 231,840 new diagnoses in the United States in 2015.
Feasibility of implementing a communitybased randomized trial of yoga for women undergoing chemotherapy for breast cancer Suzanne About 33% of women with breast cancer receive chemotherapy, 2 which can cause fatigue, depressive symptoms, poor sleep, and lower health-related quality of life (HRQoL). 3 Interventions to address these side efects, which are particularly severe during chemotherapy, are needed. 3, 4 Findings from previous studies suggest that breast cancer survivors are interested in using yoga to manage cancer-related symptoms and for their overall well-being. [5] [6] [7] Evidence supports the favorable efects of yoga on psychological functioning, [8] [9] [10] [11] [12] [13] and recent meta-analyses also suggest that yoga has moderate benefts on global HRQoL and sleep. 8, 9, 14 Evidence is inconsistent for the infuence of yoga on fatigue, with some trials reporting decreased fatigue [15] [16] [17] and others reporting nonsignifcant results. 11, 13, 18, 19 However, most of this research was conducted among women who had completed their treatment, when symptoms may be less severe. Te efcacy of yoga to address distressing symptoms during chemotherapy has received scant attention, 20 and research implementing yoga interventions has been scarce in community oncology clinics 21 compared with academic medical settings.
Te present study sought to address those gaps and build on growing evidence for the efcacy of yoga in cancer patients by targeting symptoms when they are most severe (ie, during chemotherapy) and by investigating the feasibility of ofering yoga through community-based sites. Implementation was facilitated through the Community Clinical Oncology Program (CCOP) Research Base of the Comprehensive Cancer Center of Wake Forest University in Winston-Salem, North Carolina. Te program is a member of the National Cancer Institute's CCOP network, which has been developed to increase community participation in cancer trials. 23 Tis feasibility study aimed to estimate retention in and adherence to a community-based randomized trial of yoga compared with an active control condition in women undergoing chemotherapy for stage I-III breast cancer and to obtain preliminary estimates of the efcacy of a community-based yoga intervention in women with breast cancer.
Methods

Study design
In this feasibility study, women were stratifed by CCOP site and chemotherapy status (planned within 3 weeks vs already started) and then randomized to a 10-week gentle yoga or wellness-education (active control) group with equal probability, using block randomization with randomly varying block sizes. Measures were obtained at baseline (Week 0), mid-intervention (Week 5), and immediately after intervention (Week 10). Institutional Review Boards at Wake Forest Baptist Health and the three participating CCOP sites at Greenville Hospital System, SC; Mission Hospital, Asheville, NC; and High Point Regional Health System, NC, approved this study.
Eligibility criteria
Te eligibility criteria included: women aged 18 years or older; a diagnosis of stage I-III breast cancer; being 2-8 weeks after surgery (unless receiving neoadjuvant chemotherapy); receiving or scheduled to begin chemotherapy within 3 weeks of study registration; having an expectation of continued chemotherapy during the 10-week intervention; being physically able to participate in yoga classes (ie, sit on a chair or lie on the foor); having an Eastern Cooperative Oncology Group Performance Status (ECOG-PS) of 0-2; 24 and being able to understand an informed consent document in English. Women were excluded if they: had regularly (ie, more than once a week) practiced yoga in previous 4 weeks; had participated in moderate/vigorous physical activity 3 or more days a week (on average) in the previous 4 weeks; did not plan to receive adjuvant chemotherapy; or anticipated surgery or radiation therapy during the study.
Recruitment and data collection
Physicians and nurses at each CCOP site provided study referrals. Recruitment occurred shortly after surgery or within 3 weeks of initiating chemotherapy. Tat inclusion window was intentionally broad to enhance recruitment during a potentially overwhelming time. Participants were enrolled on a rolling basis to begin attending classes as close as possible to initiation of chemotherapy. All of the questionnaires were administered and collected by a research nurse or research assistant (not blinded to group assignment) at each site.
Yoga intervention
Te yoga intervention consisted of weekly 75-minute yoga classes for 10 weeks. Participants who were randomized to yoga were asked to attend at least 8 of 10 classes. Te classes were based in the Integral Yoga tradition, which has been used successfully in previous research. 11, 25, 26 Yoga instructors had completed the Yoga Terapy for People with Cancer and Chronic Illness certifcation program (www.yogaforpeoplewithcancer.com/) and were registered yoga teachers with Yoga Alliance, an association that represents the yoga community; had 3 or more years of experience teaching yoga; and had completed a training course on yoga therapy for individuals with cancer or chronic illness. Yoga postures were taught from a mat or chair and adapted to participant ability. All of the classes included: centering and meditation, neck and shoulder movement series, upper body range of motion stretch, leg stretch, side bend, seated twist, simple supported backbend, resting pose transition, legs up the wall pose, and supported bound-angle pose. Additional poses were included as time and participant mobility allowed. 11 Yoga participants were asked to practice yoga twice a week outside of classes. Tey received a mat, bolster, strap, and a 45-minute, study-specifc yoga DVD.
27
Wellness education (active control group) Wellness education was designed to control for time, attention, and potential interactions of women in the yoga group. Participants were asked to attend at least 8 of 10 weekly, 75-minute sessions led by health educators/nurses that focused on common issues faced by women with breast cancer who were undergoing chemotherapy. Te classes included guest speakers using standardized presentation materials on symptom management; fnances/insurance; emotions and coping; communicating with providers and navigating the health care system; healthful eating, sexual issues, fertility, and body image; social support; survivorship and advocacy; and posttreatment concerns. Wellness-education participants were asked to spend 45 minutes twice a week reading the provided materials.
Measures
Demographic information was collected at baseline and included age, race/ethnicity, marital/partner status, education, and income. Clinical information was obtained from medical records and included the date and stage of the breast cancer diagnosis, treatment regimen, and current medications. Te following measures were also used:
28 a 36-item measure with established reliability and validity for measuring cancer-related quality of life. Physical, social, emotional, and functional well-being subscales, plus a breast cancer-specifc subscale, are summed to compute the total FACT-B score ranging from 0-144, with higher scores indicating better QoL. Tirteen items assessing worst severity of symptoms in the previous 24 hours are averaged to provide a score of 0-10; higher scores represent greater symptom severity. Te MDASI also measures symptom interference with 6 daily activities (general activity, mood, work, relations with others, walking, enjoyment of life) in the previous 24 hours. Te mean of the 6 items ranges from 0-10; higher scores indicate higher symptom interference. g Medical Outcomes Study Sleep Scale (MOS Sleep), 33, 34 containing 12 items that reference the previous 4 weeks. Participants report time to fall asleep and average hours of sleep per night (sleep quantity). Scores on the remaining 10 items generate a 9-item Sleep Problems Index and 6 additional subscales. Te current analysis includes sleep disturbance, sleep adequacy, and daytime somnolence. Scores range from 0-100, with higher scores indicating more of the concept being measured. Spritzer and colleagues reported that internal consistency reliability in individuals with chronic illness (N = 3,445) ranged from .75-.85. 35 
Feasibility measures
We obtained data on retention by tracking completion of study measures. Adherence was measured by total number of classes attended. Reasons for missed classes were also assessed by research nurses/assistants who called participants within 1-2 days of a missed class. Te participants completed tracking forms to assess their adherence to home activity. Participants provided feedback after the intervention (at Week 10), by rating classes and facilitators (eg, liked class, class helpful, teacher competent) on a scale of 0 (not at all) to 4 (very much). Tey also responded to open-ended questions about perceived beneft and aspects of the program they liked best or least.
Statistical analyses
Accrual of 40 participants was targeted to produce reasonably tight estimates of the parameters of interest, including attrition estimates to within 16% with 95% confdence and estimation of group means of outcome measures at each time point with a 95% confdence interval. Chi-square and Kruskal-Wallis tests assessed baseline group diferences in categorical and continuous variables, respectively. Chi-square tests assessed group diferences in retention and adherence proportions. T-tests assessed group diferences in adherence when treated as a continuous measure. Tese statistical comparisons were done at the alpha = 0.05 level of signifcance. Although the study was not powered to detect signifcant diferences between groups, these tests were performed for exploratory purposes and to allow estimation of treatment diferences. Linear mixed efects models were used to assess treatment diferences in outcomes. Models included a class variable for strata (ie, site and chemotherapy status) and were adjusted for baseline values of the outcome measure. Confdence intervals for the least squares (LS) means for outcome measures were calculated from model estimates at mean levels of covariates. Longitudinal within-group diferences were evaluated using a meaningful diference criterion of 0.5 SD. 36 All analyses were performed using SAS statistical software (SAS Institute, Cary, North Carolina).
Results
Sample
In all, 40 participants were accrued during January 2010 and August 2011 (2.1 participants/month). Of those, 22 participants were randomized to yoga and 18 to wellness education (Table 1) . Teir age range was 29-83 years (median, 48). Most of the participants (88%) were white and married (70%). Tere were no signifcant group diferences.
Study retention
Four yoga participants dropped out of the study (3 after baseline visit; 1 after Week 5). Of the 2 women who reported a reason, 1 reported fatigue and the other, difculty attending regularly. Two wellness-education partici-two 45-minute sessions a week, as instructed). Wellnesseducation participants averaged 1.1 days a week (SD, 1.5; range, 0-6) for an average of 79.4 min/week (SD, 63.4; range, 15-240).
Intervention evaluation
Participant feedback was positive and comparable between groups. On all rated items, more than 90% of participants in both groups provided favorable ratings of "quite a bit" or "very much." Yoga participants reported that they enjoyed classes, felt better after class, appreciated time for self-care, noticed decreased (fewer and less intense) symptoms and improved physical function, and liked relaxing mind and body. Suggestions for improving the yoga intervention included providing a hand-out of class components, a video that ofers varied yoga poses and sequences, ofering more than 1 class a week, and modifcations to intensify the class for women who could be more active.
Wellness-education participants reported they liked the detailed information, the time to have questions answered, and the discussions with group leaders and other participants. Suggestions to improve this program included increasing group size, providing more detailed information (eg, nutrition for estrogen-receptive positive cancer), varying the order of topics to align with women's treatment, and providing materials online.
Preliminary efcacy results
Baseline descriptive statistics and preliminary outcome data at Weeks 5 and 10 are shown in Table 3 . Because the study was not powered to detect statistically signifcant group diferences, P values are not reported. Nonetheless, a few statistically signifcant within-group diferences were identifed, along with clinically meaningful diferences using a criterion of 0.5 SD of the baseline measure. 36 Yoga participants reported statistically signifcant and clinically meaningful improvement in sleep adequacy from baseline to weeks 5 and 10 ( Figure 1 ) and a statistically signifcant and clinically meaningful decrease in sleep quantity from baseline to Week 5. Wellness-education participants reported a clinically meaningful pre-to postintervention decrease in somnolence (Figure 2 ), while their increase in sleep dis- (18) 7 (32) 2 ( 9) 4 (18) 1 ( 6) 4 (22) 7 (39) 2 (11) 4 (22) .68
Race/ethnicity Black White 2 ( 9) 20 (91) 3 (17) Original Report pants dropped out (1 after baseline visit; 1 after Week 5). Te only woman who specifed a reason reported scheduling conficts. Retention at Week 10 was 85% and did not difer signifcantly between groups (82% yoga, 89% wellness education).
Class adherence
Adherence did not difer signifcantly between groups (Table 2) , with 10 yoga participants (45%) and 7 (39%) wellness-education participants attending 8 or more classes. Two yoga and 3 wellness-education participants attended all 10 classes. Te most common reasons given for absences included: illness or fatigue (56.2%), scheduling conficts (17.8%), class canceled by teacher/facility (9.6%), child-care conficts (5.5%), forgetting (5.5%), and weather (5.5%). Among the participants who provided self-report data about home activity (55%), women in the yoga group averaged 2.0 days a week (SD, 2.0; range, 0-7) for an average of 98.4 min/week (SD, 62.8; range, 5-285; equivalent of turbance approached clinical signifcance. HRQoL showed a trend toward minimal decline among yoga participants (Table 3) . Data were not suggestive of meaningful changes in depressive symptoms or fatigue for either group. In addition, symptom severity/interference remained essentially unchanged for yoga participants, whereas interference trended toward a temporary increase in wellness-education participants.
Discussion
Tis study confrms the feasibility of implementing a community-based randomized trial of yoga and an active comparison group for women undergoing chemotherapy for breast cancer. Although the study accrued the targeted 40 participants, recruitment took longer to complete compared with previous yoga trials for women with breast cancer. 11 Women who are undergoing chemotherapy may have more demands on their time and energy than do posttreatment survivors, which possibly contributed to the protracted accrual time. Tese issues also were a factor in the relatively low adherence (<50%) in both groups, given that the most common reasons for missing classes were illness and/or fatigue and scheduling conficts. Attrition was comparable between groups, and women who completed the postintervention survey provided overwhelmingly positive feedback. Still, participants in both groups made recommendations for improvement, including more varied content of classes and home practice materials, more individually tailored activity (yoga) or information (wellness education), and more detailed guides (yoga) or accessible guides (wellness education; eg, online) for home use.
We found preliminary support for yoga to improve sleep adequacy and for wellness education to decrease somnolence. Of note, in the yoga group, women reported improvements in sleep adequacy and decreased sleep quantity, perhaps indicating that as they slept better, they needed to spend less time sleeping. In addition, symptom interference among wellness-education participants trended toward a temporary increase, whereas symptom severity and interference among yoga participants remained unchanged from baseline. Given previous evidence for yoga to improve HRQoL, depressive symptoms and fatigue in oncology samples, 11, 37, 38 the lack of improvement among yoga participants on these measures was surprising. Te lack of power in this pilot study may explain the inability to confrm previous support for the efcacy of yoga. Limited efcacy for improving HRQoL in this sample may also be explained by the gentle nature of both interventions, as more traditional physical activity for women with breast cancer tends to have greater HRQoL efects than interventions without an active exercise component. 39 Furthermore, treatment-related and depressive symptoms often correlate with HRQoL, 40, 41 indicating that increased HRQoL would have been more likely if participants' symptoms had signifcantly improved.
Because this study was conducted at a time in the disease continuum when side efects increase and HRQoL typically declines, 3 the absence of such worsening may suggest that the intervention minimized or even prevented common negative sequelae of chemotherapy. However, this possibility could not be confrmed in the current study because it did not have a usual-care control group. Moreover, although the wellness-education group was designed to control for nonspecifc efects of the group format such as social support, compared with the yoga group, the structure of the wellness-education group allowed for more interaction among participants, several of whom mentioned this as a beneft of the control group. Considering evidence for the benefts of social support 42 in women with breast cancer, this element might explain some of the favorable outcomes in the wellness-education group. Although the active control group in this study controlled for efects of time and attention, future studies could increase comparability of the nonspecifc components across intervention groups to better isolate the specifc efects of yoga. For example, yoga and active control groups should involve equivalent amounts of discussion. Future research also should include a usual-care group that controls for both nonspecifc and specifc efects.
Findings in previous research have emphasized the importance of class attendance for improving outcomes such as HRQoL. 11 Efcacy could have been hampered by low class attendance, with fewer than half of the participants in both groups attending the recommended 8 or more weekly classes. Adherence is especially problematic for timeintensive behavioral interventions if participants experience barriers identifed in previous research. 13, [43] [44] [45] Several such barriers afected the current study, because illness/symptoms and scheduling conficts were reported as the primary obstacles to attendance and study completion. Yoga participants were able to complete, on average, the recommended amount of weekly home activity, lending further support to the high acceptability of yoga among female cancer survivors 46 and suggesting that home-based yoga interventions may facilitate greater adherence than those requiring in-person attendance. Future studies might also improve adherence by incorporating participants' suggestions for improving the intervention, such as ofering multiple classes a week to allow fexibility in scheduling around illness or other commitments (eg, child care), providing more variety in both the group classes and home practice, ofering more strenuous yoga classes for participants with greater ftness, tailoring education to individual participants' phase of treatment, and supplying written and online materials.
Future research should consider use of innovative methods for delivering interventions. For example, videoconferencing technologies that allow class participation from home could enhance recruitment and adherence. 47 Online platforms could maintain nonspecifc efects such as social interaction and support 48 that may contribute to the efcacy of group-based interventions. Such delivery systems could also enhance treatment standardization by facilitating regular monitoring of treatment fdelity (eg, via recommendations from the National Institutes of Health Behavior Change Consortium) 49, 50 and by allowing a smaller number of well-trained instructors to lead yoga interventions, regardless of location. Comparing this mode of delivery to in-person interventions remains an important direction for future research.
A primary limitation of this study is the small sample size. As a feasibility study, it lacked power to make defnitive conclusions about intervention efcacy for women undergoing chemotherapy for breast cancer. Power to detect efects was also limited by inclusion of women with minimal impairment at baseline. Relatively few psychosocial oncology intervention studies have addressed patients with signifcant baseline levels of a particular symptom, despite evidence that efect sizes are highest when symptoms are elevated at baseline. 51, 52 Te lack of power may partly explain the lack of signifcant improvements in fatigue, given that a recent meta-analysis identifed a medium efect size of mind-body techniques such as yoga for decreasing fatigue during adjuvant therapy for breast cancer. 53 With mostly nonminority participants, generalizability of results is limited, although recruitment of black participants (n = 5) in this study surpassed the study goal (n = 2). Results should be replicated in fully powered studies that include minority-based community sites and tailored strategies to enhance minority participation. 54 Fully powered trials with a more diverse sample also will facilitate analysis of diferential efects of the intervention in population subgroups.
Another limitation is the lack of a usual-care control group. Including such a group in future research would help to determine whether the interventions prevented an exacerbation of symptoms and to estimate the non-specifc intervention efects. Especially given the difculty of blinding participants in yoga trials, methodological precision could be further improved by blinding study staf who obtain outcome data and by including objective measures. For example, objective measures of sleep disturbance, such as actigraphy, are an important complement to selfreport scales. 55 Moreover, infammatory cytokines may be a common mechanism linked to depression, fatigue, and sleep disturbance, 56 and evidence for the ability of yoga to reduce infammation in breast cancer survivors is beginning to emerge. 57 
Conclusions
Tis study demonstrated the feasibility of implementing a community-based randomized trial of yoga and an active comparison group for women undergoing chemotherapy for breast cancer and provided preliminary efcacy data. Fully powered trials with a usual-care control group and objective measures are needed to confrm the potential for yoga to improve sleep and mitigate treatment-related symptoms during chemotherapy. Obstacles to conducting yoga research during breast cancer treatment include fatigue and scheduling difculties among participants, as well as limited access to cancer-specifc yoga classes. To reach women with breast cancer during the critical time of chemotherapy treatment, future studies will need to use novel methods to enhance adherence by increasing access to and variety in yoga classes and materials.
